Drug intelligence / Profile preview

ISLA-6181

Development stage
Preclinical
Lead developer
Island Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

ISLA-6181 is a small molecule antiviral candidate being developed by Island Pharmaceuticals (formerly Isla Pharmaceuticals). Currently in the IND-enabling stage, it is characterized as a host-targeting antiviral (HTA) designed to treat various viral infections, potentially including flaviviruses such as Dengue and Zika. As a next-generation HTA, it aims to inhibit host cell proteins that viruses exploit for replication, thereby providing a broad-spectrum therapeutic approach with a higher barrier to viral resistance compared to direct-acting antivirals. The drug's mechanism involves blocking the nuclear transport of viral proteins, which prevents the virus from suppressing the host's innate immune response.

Other names
ISLA-6181ISLA6181ISLA 6181
02

Targets

NS5 (Flavivirus nonstructural protein 5)Importin alpha/beta1 heterodimer

Beyond the preview

Go deeper on ISLA-6181.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ISLA-6181.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call